Indeed transgenic mice overexpressing human amyloid precursor protein (APP) develop early AD-like changes, including diffuse, extracellular Aβ deposits in the brain, and specific spatial learning and pneumonic deficits [54]–[57]. Here, APP is linked to Alzheimer disease.